<--- Back to Details
First PageDocument Content
Reproductive system / Contraceptive patch / Evra / Oral contraceptive formulations / Ethinylestradiol / Transdermal patch / Norelgestromin / Emergency contraception / Estradiol / Hormonal contraception / Endocrine system / Medicine
Date: 2009-03-31 14:09:07
Reproductive system
Contraceptive patch
Evra
Oral contraceptive formulations
Ethinylestradiol
Transdermal patch
Norelgestromin
Emergency contraception
Estradiol
Hormonal contraception
Endocrine system
Medicine

ORTHO EVRA (norelgestromin/ethinyl estradiol) Label, NDA[removed]supplement 26

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 605,74 KB

Share Document on Facebook

Similar Documents

FDA revises restriction on over-the-counter access to Plan B emergency contraception to women 17 and over

DocID: 1vekW - View Document

Emergency Contraception: Know the Facts! MYTH: Emergency contraception (EC) is an abortifacient and will end a pregnancy. FACT: EC is contraception that prevents pregnancy after sex. It will not harm

DocID: 1uTDQ - View Document

For Immediate Release October 15, 2015 Contact: (The Native American Women’s Health Education Resource Center Successful in Assuring Access to Emergency Contraception at Indian Health Service. After five

DocID: 1uqfw - View Document

EMERGENCY CONTRACEPTION History and Access Every woman deserves every chance to prevent an unintended pregnancy. Emergency contraception (EC) provides women with a second chance at

DocID: 1tBfR - View Document

Midwifery / Health / Human geography / Demography / Family planning / Emergency contraception / Prevalence of birth control / Unintended pregnancy / Reproductive health / Marie Stopes International / Birth control / Millennium Development Goals

Afghanistan* Bangladesh* Benin* FP2020 COMMITMENT TO ACTION: MEASUREMENT ANNEX 2015

DocID: 1rafx - View Document